AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States

<img class=”alignnone size-full wp-image-269347 aligncenter” src=”https://businessnewsthisweek.com/wp-content/uploads/2024/11/AstraZeneca.jpg” alt=”AstraZeneca invests $3.5 billion in R&amp;D and manufacturing in the United States” width=”640″ height=”432″ />
<p style=”text-align: justify;”><strong>November 16, 2024,Cambridge, England :</strong> AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy.</p>
<p style=”text-align: justify;”>AstraZeneca’s expanding footprint in the US includes, among others:</p>
<p style=”text-align: justify;”>A state-of-the-art R&amp;D centre in Kendall Square, Cambridge, Massachusetts
A next generation manufacturing facility for biologics in Maryland
Cell therapy manufacturing capacity on the West and East Coasts
Specialty manufacturing in Texas</p>
<p style=”text-align: justify;”>Pascal Soriot, Chief Executive Officer, AstraZeneca said: “Our multibillion dollar investment reflects the attractiveness of the business environment together with the quality of talent and innovation capabilities here in the United States. By expanding our R&amp;D and manufacturing footprint, we aim to enhance the development of cutting-edge therapies and support the United States leadership in healthcare innovation.”</p>
<p style=”text-align: justify;”>Delivering growth: Ambition 2030</p>
<p style=”text-align: justify;”>These US investments are the first of a series of important steps to help deliver AstraZeneca’s ambition to achieve $80 billion in Total Revenue by 2030 as set out in May this year. A key element of our strategy is accelerating the Company’s development in the United States. The US is AstraZeneca’s largest market, generating 44% of its Total Revenue.1</p>
<p style=”text-align: justify;”>AstraZeneca in the US</p>
<p style=”text-align: justify;”>AstraZeneca has approximately 17,800 employees working across 17 R&amp;D, manufacturing and commercial sites spanning 12 states.</p>